United Kingdom · Question · Written question
UIN 28293
Trastuzumab Deruxtecan
Original
Introduced
3 February 2025
Last action
11 February 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
11 February 2025
Summary
To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of levels of access to Enhertu for cancer patients in (a) England, (b) Wales, (c) Northern Ireland and (d) Scotland.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 February 2025
Written question
To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of levels of access to Enhertu for cancer patients in (a) England, (b) Wales, (c) Northern Ireland and (d) Scotland.
Source: Commons
11 February 2025
Answer
No assessment has been made, as health is a devolved matter and decisions on the availability of medicines in Scotland, Wales, and Northern Ireland are a matter for their own administrations.Decisions on whether new medicines should be routinely funded by...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-02-03/28293
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1761338
- uk · wq-1761338 · source updated 11 February 2025